Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Cohance Lifesc Cohance Lifesciences Ltd. | BSE 361.90 -7.45 (-2.02%) | NSE 361.20 -8.00 (-2.17%) | Trade | Add

BSE Live

Apr 21, 16:01

361.90 -7.45 (-2.02%)

Volume

AVERAGE VOLUME

5-Day

17,800

10-Day

17,817

30-Day

23,635

211,056

Prev. Close

369.35
Open Price

369.35

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 21, 15:59

361.20 -8.00 (-2.17%)

Volume

AVERAGE VOLUME

5-Day

249,599

10-Day

282,567

30-Day

675,950

1,906,810

Prev. Close

369.20
Open Price

369.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
361.20 (5416)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Cohance Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,068.31	1,009.49	1,320.86	1,307.01	995.46
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	1,068.31	1,009.49	1,320.86	1,307.01	995.46
Total Operating Revenues	1,093.51	1,024.99	1,330.08	1,320.22	1,009.72
Other Income	53.98	55.09	44.55	187.79	14.24
Total Revenue	1,147.49	1,080.09	1,374.63	1,508.01	1,023.96
EXPENSES
Cost Of Materials Consumed	212.51	248.38	421.36	459.46	310.32
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	0.00
Operating And Direct Expenses	0.00	127.78	170.87	173.19	122.73
Changes In Inventories Of FG,WIP And Stock-In Trade	86.53	53.88	-20.94	-60.35	-8.37
Employee Benefit Expenses	198.30	126.88	100.84	100.48	87.29
Finance Costs	8.00	7.43	5.39	6.23	9.14
Depreciation And Amortisation Expenses	57.20	48.79	42.84	39.10	31.64
Other Expenses	233.60	58.17	74.87	67.46	57.23
Total Expenses	796.14	671.31	795.24	785.56	609.98
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	351.35	408.77	579.39	722.45	413.98
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	351.35	408.77	579.39	722.45	413.98
Tax Expenses-Continued Operations
Current Tax	85.80	98.14	144.63	157.63	101.54
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-12.73	6.59	4.34	6.72	3.62
Tax For Earlier Years	6.57	-0.78	-2.17	0.00	0.18
Total Tax Expenses	79.64	103.96	146.79	164.35	105.33
Profit/Loss After Tax And Before ExtraOrdinary Items	271.71	304.82	432.60	558.10	308.65
Profit/Loss From Continuing Operations	271.71	304.82	432.60	558.10	308.65
Profit/Loss For The Period	271.71	304.82	432.60	558.10	308.65
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	10.67	11.97	16.99	21.92	12.12
Diluted EPS (Rs.)	10.62	11.97	16.99	21.92	12.12
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	203.65	101.83	25.46
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	0.00	0.00	600.00	500.00	200.00